Metabolic pathway presents promising new target for treating rare, aggressive childhood cancer

A new study delving into the genetic drivers of a rare and aggressive childhood cancer called Malignant Peripheral Nerve Sheath Tumor (MPNST) has revealed metabolic frailties in the cancer cells that might be exploited to improve treatments for patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup